Seraphina Therapeutics Recognized in the Inc. 5000 List
Seraphina Therapeutics has made a significant mark in the business world by securing a spot at No. 177 on the prestigious Inc. 5000 list for the year 2025. This list is known for celebrating America’s fastest-growing private companies, showcasing their impressive growth over the past three years.
Record-Breaking Revenue Growth
With astounding three-year revenue growth reaching 3,031%, Seraphina Therapeutics has firmly established itself as a standout performer. Their innovative product, fatty15, a C15:0 longevity supplement, has propelled the company to the forefront of the health and wellness industry.
Achievements and Recognitions
Seraphina's remarkable journey to this accolade underscores their commitment to improving lives globally. Dr. Eric Venn-Watson, co-founder and co-CEO, expressed pride in the company’s accomplishments, highlighting their mission to make a meaningful impact on health and wellness.
The Journey of fatty15
Launched in January 2021, fatty15 not only stands out as a first-of-its-kind supplement but also boasts a remarkable customer retention rate of 95%. With over 100,000 active subscribers, it clearly resonates with its audience, demonstrating a strong demand for its health benefits.
Community Impact and Job Creation
The Inc. 5000 list reflects a broader economic trend, with its honorees contributing to the creation of approximately 48,678 jobs in the U.S. over the past three years. The median revenue growth rate among the top 500 businesses is 1,552%, showcasing resilience even amid economic challenges.
Upcoming Celebrations and Future Prospects
Seraphina Therapeutics is set to be honored at the upcoming Inc. 5000 Conference & Gala, which will celebrate the achievements of these remarkable companies. This gathering not only highlights their successes but also reinforces the entrepreneurial spirit that powers the U.S. economy.
Continued Expansion
As Seraphina Therapeutics continues to innovate and expand its product lines, their commitment to enhancing overall health remains unwavering. The company's growth trajectory positions it as a leader in the wellness sector, fundamentally changing how consumers view nutritional supplements.
Methodology for Selection
The Inc. 5000 listings rank companies based on percentage revenue growth over a specific period. To qualify, businesses must be U.S.-based, privately held, and show consistent growth patterns, ensuring that only the best are recognized.
About Seraphina Therapeutics
Seraphina Therapeutics is dedicated to developing innovative health solutions to improve quality of life. The pioneering work by its founders reflects a deep commitment to health and wellness that resonates with many. With ambitious plans for the future, Seraphina Therapeutics is set to make waves in the health industry.
Frequently Asked Questions
What is the Inc. 5000 list?
The Inc. 5000 list ranks the fastest-growing private companies in America based on their revenue growth over three years.
What product did Seraphina Therapeutics launch?
Seraphina Therapeutics launched fatty15, a C15:0 longevity supplement that has contributed significantly to the company’s growth.
What are Seraphina's future plans?
Seraphina Therapeutics aims to expand its product lines and continue to enhance health solutions for consumers worldwide.
How many jobs have Inc. 5000 companies created?
Companies on the Inc. 5000 list have collectively added over 48,678 jobs to the U.S. economy in the past three years.
What is unique about fatty15?
Fatty15 is noted for its high customer retention rate and effectiveness, making it a unique product in the longevity supplement market.
